Showing 5861-5870 of 20937 results for "".
- Neuroendocrine Pathways and Obesity: Unveiling the Secrets of Appetite and Energy Regulationhttps://reachmd.com/news/neuroendocrine-pathways-and-obesity-unveiling-the-secrets-of-appetite-and-energy-regulation/2476118/The intricate dance between hormones and neurons governs our appetite and energy utilization, laying the foundation for understanding obesity. Neuroendocrine pathways play a central role in regulating appetite and energy balance by integrating peripheral hormonal cues with hypothalam
- Unraveling Complex Allergies: New Frontiers in Treating Eosinophilic Esophagitis and Oral Anaphylaxishttps://reachmd.com/news/unraveling-complex-allergies-new-frontiers-in-treating-eosinophilic-esophagitis-and-oral-anaphylaxis/2476105/Facing a surge in food allergies, healthcare providers find themselves grappling with treatment limitations. Improved understanding of inflammatory responses in conditions like Eosinophilic Esophagitis (EoE) and oral anaphylaxis heralds new therapeutic pathways. Buil
- Breakthroughs in Glomerular Disease: Pegcetacoplan and Combined CKD Therapieshttps://reachmd.com/news/breakthroughs-in-glomerular-disease-pegcetacoplan-and-combined-ckd-therapies/2476106/In the evolving landscape of nephrology, the FDA approval of pegcetacoplan is marking a significant advancement in the management of complement-mediated kidney diseases, highlighting how clinicians are grappling with evolving strategies for C3 glomerulopathy (C3G) and immune complex
- AI-Driven Eczema Management: Revolutionizing Dermatology with Smartphone Technologyhttps://reachmd.com/news/ai-driven-eczema-management-revolutionizing-dermatology-with-smartphone-technology/2476120/Artificial intelligence is advancing the dermatology field by enabling remote and more consistent eczema assessments through smartphones. This technological evolution is empowering patients with better self-care capabilities and providing dermatologists with innovative tools to enha
- Navigating the Complex Path of Neuroendocrine Carcinoma with Membranous Nephropathy: An In-Depth Analysishttps://reachmd.com/news/navigating-the-complex-path-of-neuroendocrine-carcinoma-with-membranous-nephropathy-an-in-depth-analysis/2476110/When the complexity of rare malignancies intersects with renal complications, the diagnostic and therapeutic horizon is both challenging and urgent. Imagine a landscape where cancer and kidney disease not only coexist but actively complicate each other's course, creating a labyrinthine path
- Exploring Exercise-Based Alternatives in Obstructive Sleep Apnea Managementhttps://reachmd.com/news/exploring-exercise-based-alternatives-in-obstructive-sleep-apnea-management/2476094/The search for alternatives to continuous positive airway pressure (CPAP) is expanding as patients with obstructive sleep apnea (OSA) increasingly seek non-traditional treatment strategies. Exercise-based therapies are gaining attention, particularly for their role in strengthening upper ai
- Understanding the Neurobehavioral Mechanisms of Fear and Anxiety in Multiple Sclerosishttps://reachmd.com/news/understanding-the-neurobehavioral-mechanisms-of-fear-and-anxiety-in-multiple-sclerosis/2476096/Fear and anxiety loom large in the lives of individuals with Multiple Sclerosis (MS). These emotional states are not merely reactions to the condition; they are entwined with the neurobehavioral mechanisms of the disease itself. This complex interplay challenges healthcare providers
- Unmasking Ultra-Processed Foods: Risks and Public Health Solutionshttps://reachmd.com/news/unmasking-ultraprocessed-foods-risks-and-public-health-solutions/2476097/Ultra-processed foods are increasingly prevalent in the food system, raising urgent concerns as consumption climbs and health burdens reshape clinical priorities. A recent
- Navigating Thyroid Cancer: The Hashimoto’s Linkhttps://reachmd.com/news/navigating-thyroid-cancer-the-hashimotos-link/2476098/In recent propensity score–matched research (HR=0.65, 95% CI [0.45–0.85], p=0.003), clinicians observed that Hashimoto’s thyroiditis appears to modulate tumor behavior differently in younger women versus older men. Specifically, glandular inflammation in premenopausal patients was linked to
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://reachmd.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie